首页> 外文期刊>Cyclodextrin news >Design and Evaluation of Folate-appended Methyl-β-Cyclodextrin as an Active Pharmaceutical Ingredient for Cancer Treatment
【24h】

Design and Evaluation of Folate-appended Methyl-β-Cyclodextrin as an Active Pharmaceutical Ingredient for Cancer Treatment

机译:叶酸成熟的甲基-β-环糊精作为癌症治疗的活性药物成分的设计和评估

获取原文
获取原文并翻译 | 示例
           

摘要

Chemotherapy is expected to destroy the tumor cells with maximum treatment efficacy,while minimizing side effects to normal tissues.However,in the application of conventional anticancer agents,there are some unexpected limitations such as poor distribution in tumor sites,impairment of normal tissue,and lack of target specificity.In order to overcome these drawbacks,the various techniques of drug delivery for tumor cells have attracted considerable attention.To provide an active targeting-ability to a drug carrier,chemical modification by tumor targeting ligands is known,such as antibody,sugar,folic acid(FA),transferrin,and epidermal growth factor.
机译:预计化学疗法将以最大的治疗功效破坏肿瘤细胞,同时最大程度地减少对正常组织的副作用。但是,在应用常规抗癌药物的应用中,存在一些意外的局限性,例如肿瘤部位的分布较差,正常组织损伤和 缺乏目标特异性。为了克服这些缺点,肿瘤细胞的药物递送的各种技术吸引了很大的关注。为了为药物载体提供主动靶向性,通过靶向配体的化学修饰,例如抗体,例如 ,糖,叶酸(FA),转铁蛋白和表皮生长因子。

著录项

相似文献

  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号